chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sudden onset of chills, shakes, then alternating fever and chills. Full body aching. Very lethargic next day with some shaking and fever and chills. Second day same symptoms, but milder. Third day able to function in house, but not comfortable enough to leave. 92% recovered by fourth day.
Site: Swelling at Injection Site-Mild, Additional Details: The patient had a little bleeding, then the area swell a little bit after using a cotton swab to clean it up. the pt was fine and went home, and the swelling was almost gone after 15 minutes.
ABOUT 45 MINUTES AFTER RECEIVING VACCINE AND LEAVING OFFICE, PATIENT STARTED FEELING UNWELL.  WEAK, FLUSHED, SOB, PANTING ALSO PALE AND DIZZY.  CALLED ON CALL PHYSICIAN.  FEELING BETTER, STRONGER BY 02:30 PM.  PATIENT DECLINED IN TO CHECK.
Received Influenza vaccine 2:20PM November 23rd, 2004 - at @ 2:45 PM that day - vaccination site began to itch - noted erythema and swelling insued. By 3PM swelling and redness to elbow joint. Scratchiness of throat and shortness of breath followed. Notable wheezing and uticaria of mouth and nose.  Oxygen saturation 92% on room air - 50mg oral benadry given, BP 68/42; IV started 3:10PM - 80mg solumedrol via IV.  oxygen give at 2L;  Albuterol 2.5mg via neb. Monitored for two hours - injection site continued to be red and swollen - breathing and itching improved post medication administration - sent home with Prednisone 20mg daily for 5 days; Benadryl 25mg daily for three days; albuterol inhaler 2 puffs as needed for shortness of breath. Medical Record received on 1/03/2005 states hypotension.
Teen developed an urticarial widespread rash within 4 hours of receiving the vaccine. She was tested and positive on 7/31( the next day) for EBV( mono) and adenovirus. Her rash progressed and her throat that was inflamed a few days prior to the  vaccine became markedly worse and  she  needed high dose steroids to improve. She had some mildly abnormal labs with increased eosinophils, AST/ALT and creatinine of just over 1. As of 8/4, she is still very itchy but otherwise improving daily.
Low grade fever (100), malaise, coryza, diffuse macularpapular rash
red, swollen eyes, chest constriction, phlegm in throat, coughing, low blood pressure (80 over 60)
WHEN  HE TOUCHES ARM HE HAS SHARP PAIN; CHRONIC FATIGUE; This spontaneous report received from a pharmacist concerned a 47 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced when he touches arm he has sharp pain, and chronic fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from when he touches arm he has sharp pain, and chronic fatigue. This report was non-serious.
No additional AE details; Customer calling for TE evaluation of VARIVAX. Customer states she called yesterday 5/24/2022 to report a TE but they just found out they had another TE 1 week ago and they need to report that at this time. VARIVAX has been administered to a total of; This spontaneous report was received from a customer referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      Between 11-MAY-2022 and 24-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot number U039949, expiration date 12-DEC-2023 (dose and route of administration not provided) for prophylaxis and that was reconstituted with a sterile diluent (product storage error). No adverse event was reported.  The excursion was between -14 degrees Celsius (°C) to 10 °C for 2 hours and 5 minutes and between -10°C to 8°C with an average of -0.4°C for 1 hour and 25 minutes. A previous temperature excursion was deteceted and was between -14°C to -10°C with an average of -12°C for 50 minutes.
Patient's left arm became harden with pain. He rate it at pain scale of 9. The area was red according to patient but lessen the next day.
approx 2wk p/vax pt exp low grade fever, severe joint pain & swelling, chronic fatigue & the onset of Raynaud's synd;pt was dx w/polyarthritis & systemic lupus erythematosus in 1993;Annual follow-up dated 10/02/00 states a tentative diagnosis of vasculitis.
Within 24 hours post vax, the pt developed an injection site reaction characterized by a 5 inch area of redness, swelling, and warmth. He was treated symptomatically and recovered.
Pt recvd vax & exp lightheadedness, h/a, nausea & a funny feeling in chest; BP was 150/100; pt presented to MD for eval; BP had dropped to 120/70; pt subsequently recovered; No further details were provided;
Patient was administered with moderna covid-19 vaccine for 6-11 yrs of age instead of the updated moderna bivalent booster
Patient states that the next morning about 7:30 after receiving vaccines she noticed Right upper arm was sore, red and warm to touch. States she started running fever that got up to 101.6, had a headache, felt weak in both legs and had nausea. Area is about 4 inches in diameter on R deltoid. Is red, swollen and warm to touch today. Fever broke last night patient states.
1 hour after receiving vaccine both hands began to swell.  Swelling lasted for +36 hours with no other symptoms.  No medical Rx required.  No medications taken.
LOCAL RXN R THIGH W/IN MINUTES WITH BLOTCHY ERYTH.
48hr chills, pain, redness @ site, pain walking, sweats-feverish;gen body aches, swelling @ site;22MAR swelling got worse;a cellulitis
On 12/8/2022 at about 7-8 PM, I began to have a scratchy, sore throat. At around 6:30 AM on 12/9/2022, I woke up with a fever, chills, muscle aches, joint pain, headache, and nasal congestion. I then took a home antigen test and got a positive result. At 11:25 AM the same day, I also underwent a PCR test, and I got a positive result back on 12/10/2022. At this time, I began taking PAXLOVID. Later in the evening on 12/9/2022, I developed chest congestion and cough. On 12/10/2022, my symptoms continued to worsen, and I had some difficulty breathing. It was around this time that I began the PAXLOVID therapy. I was bedridden on 12/10/2022 and 12/11/2022. On 12/12/2022, my symptoms began to lessen. On 12/14/2022, I finished taking the PAXLOVID. By 12/15/2022, my symptoms had resolved. I was out of work between 12/9/2022 and 12/15/2022. On 12/16/2022, I did remote work. On 12/19/2022, I was able to return to the office. Sometime in January 2023, I began to develop mild hypertension. My blood pressure reading was around 130/80; before then, it was usually 120/70. By April 2023, it had increased to 150/90. On 4/19/2023, it was 170/100. At that time, my PCP did bloodwork. Everything was within range, except my serum creatinine had risen to 1.34, with a GFR of 64.5. My PCP then prescribed me losartan/HCT (50-12.5). In March-April 2023, I began to experience chronic fatigue and vascular headache. Despite having normalized blood pressure after beginning the losartan/HCT, I have continued to have chronic fatigue and vascular headache. As a result, on 5/25/2023, my PCP repeated bloodwork. My serum creatinine had risen to 1.41, and my GFR had dropped to 60.3. Because of that, I underwent a renal ultrasound on 5/31/2023, with additional testing. My PTH was notably elevated at 154.2. This means that I have now have chronic kidney disease, stage 2. I have a nephrology appointment in a few days.
Pt reports she saw Dr for "horrible blurred vision...and flashes on the left side of my left eye". Reports she also had increased coughing (forceful) at the time w/Bronchitis-like symptoms. States she saw her internist after Christmas due to continuation of respiratory symptoms (see #18) & headache (L) side of head. MD suggested head MRI - she has not had this yet. Symptoms mainly reports were at the Flu injection site was "red and raised --- tender to touch" for 2 months tried ADVIL & other pain meds with much relief. Resolved 1 month ago (early February 2009 but is still "raspy".
Headache, Myalgia, Fever, Hurts to deep breath, 10/10 bodyaches, headache, fever/chills Narrative: Advised employee to go to the Urgent Care close to his house or the ED as soon as possible. Advised he call a friend to drive him. Employee is able to speak in full sentences without SOB. Has been taking. Ibuprofen and Tylenol alternating for pain and fever with minimal relief.
Information has been received from a registered nurse concerning a 24 year old female patient with no known allergies who on 04/09/00 was vaccinated in the left deltoid with the first dose of pneumococcal vaccine 23 polyvalent (lot #630097/0045J)/ On 04/24/00, the patient experienced a severe local reaction in the left deltoid region. It was noted that the estimated area was approximately 4-5 cm and warm and firm,but not fluctant. The patient's temperature was 99.5 degrees fahrenheit and she had been taking Tylenol. On an unspecified date,the patient recovered. Two other patients (WAES numbers 00051264 & 00070168) had similar experiences. No furhter information is available.
Daily headaches for 45 days. Right neck lymph node swelling for 1 week.
Nausea, vomiting, fainting, chest pains, arm/hand turned blue. Transported via ambulance to er for being unconscious
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-689916 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Follow-up received wherein Age group added and I narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-689916:Master case
Fever of100.8, chills, body aches, headache, fatigue (tiredness).  Symptoms started about 12 hours after second dose (at midnight) and lasted a full 24 hours; took two Tylenol every six hours (about 3 doses); felt OK the following day
2/9/22 To ED with 3 days of bilious/nonbloody vomiting, fever, and headaches with 1 day onset of watery diarrhea since the morning. Fevers with a T-max of 103.3 F. Patient more sleepy & appetite decreased significantly. Prior to arriving to the ED, mom noticed a faint rash on his torso that had resolved "for the most part." Per mom patient tested positive for Covid three weeks ago but remained asymptomatic w/o complications. Fully vaccinated. Admitted for COVID associated MISC. Infectious disease followed. ID following. 2/10 Received 1 dose of IVIG 2g/kg run over 8 hours and methylprednisolone 30 mg/kg. Echo showed normal intracardiac connections and normal biventricular systolic function. Pancytopenia- worsened, 2/10 WBC 4.5  RBC 3.88  Hgb 10.6  Hct 30.5 L   Adenovirus was high on DDx, but RVP since returned negative, making MIS-C the likely diagnosis. Inflammatory markers stable. FU labs tomorrow to trend. Pt now afebrile for at least 16 hours, and otherwise HDS on RA. Discussed with ID re: negative COVID Ab. With known hx of COVID, the negative test does not preclude the diagnosis. There is also the possibility of post-vaccine MISC (not common) but again with his known hx within 4 weeks it fits the diagnosis regardless. 2/12 Patient improving based on lab work and clinical assessment. He is tolerating fluids and small amounts of solid food with mild nausea. He remains afebrile and HDS. Patient is stable for discharge
Red swollen knot turned into open sore, then 2 more knots about 2 wks later turned into open sores. They all grew until they became one huge open sore on my arm and then the final knot is by my armpit that became an open sore.
Headache, swollen lymph node on the left clavicle, all over body aches, fatigue
Individual reports his symptoms began approximately one week following his BIOTHRAX #2 and Yellow Fever immunization and have persisted unchanged. He reports bilateral hand stiffness, bilateral shoulder pain, increase in pain in right shoulder (has a history of right shoulder pain), joint pain, fatigue, decrease in strength generalized, decrease in grip strength and persistent burning at both right and left arm injection sites. He reports he had an evaluation by his personal physician and blood laboratory testing is planned. Follow up received on 24MAY10-Slowly improving, noticing most improvement in lessening of fatigue symptoms. He reports his doctor said his blood work was "great". Follow-up received on 24JUN10-Continues to experience decreased grip strength. X-ray of both hands reported as "normal". His other symptoms are improving; his general strength is much better. He no longer experiences burning at injection sites.
Upon injection into patient's left arm, administrator felt resistance.  No vaccine was injected.  Needle was withdrawn and swelling was observed.  No pain or itching was observed by patient.  Administrator observed patient for several minutes and noticed that swelling decreased.  Patient was sent home for follow-up appointment 3 days later.  Vaccine was administered in right arm with no incidence.
Patient was vaccinated with COVID19 vaccine.  Within approx 2mins patient became clamy, pale, and had a syncopal episode.  Patient was seated at the time of the episode.  Patient regained conciousness and stated this has happened once before when having blood drawn.  EMS was onsite of vaccine clinic and responded immediatley.  Patient was evaluated by EMS and it was decided patient will be brought to the hospital.  While being put into the rig the patient again said he felt faint and had another syncopal episode. EMS loaded patient into the rig and brought him to hospital.  ALS was called by EMS which they met with enroute to Hospital
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: ems called out of caution  patient exhibited low blood pressure as well  ems took vitals and patient was fine after about 30min  patient declined further care
Day after headache, arm sore, and felt bad for about 5 hours. One week later the same arm was red, hot and swollen the whole upper arm and it was hard. Underneath lymph node swelling and tenderness.
Pt recvd vax & 2 wks p/vax exp bitter taste; resolved in 10 days;
Pt developed 15-20  chicken pox lesions 14 days after vaccine given. Had fever 103 with this.
pt was seen for PE on 12JAN93 & recvd vax that day; that evening pt devel fever to 102 for 2 days, as well as runny eyes & cough; pt brought to clinic on 19JAN93 w/poss rxn as the presenting c/o; MD reported poss vax rxn or viral infection;
This spontaneous report was received from a registered nurse and referring to a patient of an unknown age and gender. There was no information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies, and drug reactions or allergies. On 16-FEB-2017, the patient was vaccinated with an expired dose of M-M-R II lot number: L004656, expiration date: 11-FEB-2017 (strength, dose, frequency, route of administration, and anatomical location were not provided) for prophylaxis. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
My wife had booster vaccination on Feb 07, 2022. Next day she felt numbness in her toes and then next day the numbness was in her both feet, which next day travel towards her legs and the abdomen and then chest. Now power of her left leg is 0/5 and right 2/5. The diagnosis at first was transverse myelitis, which after MRI confirmed as Longitudinally extensive transverse myelitis (LETM). And after positiove AQ4 anti bodies test it is diagnosed as Neuromyelitis optica Spectrum Disorder(NMOSD). As per doctors It is very likely due to Pfizer Covid 19 booster. And I am sure it is due to Pfizer Covid 19 booster vaccination. Please help us to treat the disease which is occurred as result of Pfizer Covid Booster.
Moderna vaccine vial was opened on 12/30/2020, and the vial was placed back into the fridge later that afternoon, like 2-3 hours after puncture. The opened vial was reused for this patient the next morning for an injection when it should have been discarded. No adverse events occurred
significant local reactions to Bexsero-Itching; significant local reactions to Bexsero-Redness; significant local reactions to Bexsero-swelling; Concerned that this may have been an allergic reaction; This case was reported by a physician via sales rep and described the occurrence of localized itching in a patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced localized itching, localized erythema, local swelling and allergic reaction. On an unknown date, the outcome of the localized itching, localized erythema, local swelling and allergic reaction were unknown.   It was unknown if the reporter considered the localized itching, localized erythema, local swelling and allergic reaction to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows:   The age at vaccination was not reported. The patient had significant local reactions like redness, swelling & Itching to Bexsero.  The reporter was concerned that this might have been an allergic reaction. The physician was not planning on giving 2nd dose. The reporter did not give consent to follow-up.
feeling tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 40 year-old female patient received bnt162b2 (BNT162B2), administration date 16May2021 12:45 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose no -1), for Covid-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset May2021, outcome "unknown", described as "feeling tired".  Additional information: Caller was calling on behalf of her daughter who took her second Pfizer Covid vaccine dose on16May2021. She reported her daughter was feeling tired and wanted to know if this was a normal side effect of the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A few days (can not remeber exact day) after receiving my SECOND Covid 19 dose on September 7, 2021 with the same Pfizer vaccine I experienced a major flare of Meneir's disease.  I had extreme vertigo, hearing loss and tinnitus.  The vertigo subsided after several days but to this day I suffer from severe hearing loss and tinnitus.  I have had flares of Meneir's in the past but they have always slowly subsided after about 3 weeks.  I am now in month 5 with no measurable change in hearing.
The client presented to the Forum with his mother for his first dose of vaccine. The client was veted and a consent form was obtained.  It was identified after the client was vaccinated that the client did not meet the eligibility criteria. The client was educated on Pfizer side effects and adverse reaction. The client/mother was informed that the client can not receive his second dose until he turns 16 years of age.  The client was observed with no side effects or adverse reaction noted.  Education was reinforced amongst the staff.
Began feeling hot, sweaty and somewhat lightheaded. Attempted to "walk it off" but after approximately 5 minutes I had to sit down on the floor with my legs crossed to prevent fainting. Loss of vision (cloudy/white light) and hearing (loud ringing.) After approximately 30-45 seconds I regained my hearing and vision and was able to stand again. Continued to walk around the pharmacy, then left and sat in my vehicle until I felt normal again. Total time passed between nearly fainting and feeling normal enough to drive was approximately 15 minutes.
This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough) and HYPERHIDROSIS (Sweat) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter.  On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Cough) and HYPERHIDROSIS (Sweat). At the time of the report, COUGH (Cough) and HYPERHIDROSIS (Sweat) outcome was unknown. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate increased: 140 (High) not provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications include medicine for Atrial Fibrillation. No treatment information available. Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Non significant follow up was received on 07 june 2021 the patient stated that wanted to update safety with his assumption
Patient reported that they were developing rash on arms and legs. She showed them to me and her skin got redder in about 30mins. I suggested she take BENADRYL orally or apply over the counter hydrocortisone and that I would call her DR while she waited. Nurse at dr's office said for patient to take BENADRYL and head down from pharmacy to Dr office so that patient can be seen. Patient got the BENADRYL and said she would go to Dr's office.
Head to toe rash and headache. Reported by parent, did not see rash. Referred to family doctor. Unable to reach client for follow- up information.